{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:53:53Z","timestamp":1782482033825,"version":"3.54.5"},"reference-count":31,"publisher":"Baishideng Publishing Group Inc.","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCC"],"published-print":{"date-parts":[[2021,7,6]]},"DOI":"10.12998\/wjcc.v9.i19.5217","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:31:23Z","timestamp":1624426283000},"page":"5217-5225","source":"Crossref","is-referenced-by-count":13,"title":["Treatment of leiomyomatosis peritonealis disseminata with goserelin acetate: A case report and review of the literature"],"prefix":"10.12998","volume":"9","author":[{"given":"Jia-Wen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Zhong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2018.06.004"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2009.01.013"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3684282"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519859137"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2017.09.016"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1066896919880962"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000164949"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20824"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.893570"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(03)00237-9"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199907000-00012"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(99)00587-6"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(81)90440-3"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0637-1"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.848"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2741"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2019159"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000178761"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.08.580"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000156298.74317.62"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000090628"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2014.05.029"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318180219b"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13376"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(11)91445-8"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10397-013-0816-2"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003112"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2008.07.001"},{"key":"B29","unstructured":"European Medicines Agency.   Esmya: new measures to minimise risk of rare but serious liver injury. [cited 5 December 2020]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/esmya"},{"key":"B30","unstructured":"European Medicines Agency.   PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids. [cited 5 December 2020]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ulipristal-acetate-5mg-medicinal-products"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2016.1139833"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v9\/i19\/5217.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:38:21Z","timestamp":1624426701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v9\/i19\/5217.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":31,"journal-issue":{"issue":"19"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v9.i19.5217","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}